经林业发展局批准的新的TIL疗法利用病人的免疫细胞来有效防治先进的黑素瘤。 New FDA-approved TIL therapy uses patients' immune cells to combat advanced melanoma effectively.

由林业发展局批准的对高级黑素瘤的新治疗,称为Tumor-Invisitation-Lymphocyte疗法(TIL),使用病人自己的肿瘤和免疫细胞来防治这一疾病。 A new FDA-approved treatment for advanced melanoma, called Tumor-Infiltrating-Lymphocyte (TIL) therapy, uses a patient's own tumor and immune cells to fight the disease. 这种治疗是病人的第二个或第三个选择,在Schneider's等案例中显示了希望,它帮助他从第四阶段黑瘤中恢复过来并恢复正常生活。 The treatment, a second or third option for patients, has shown promise in cases like Schneider's, where it helped him recover from stage four melanoma and return to normal life. 专家认为,这种疗法将来也可以治疗其他癌症。 Experts believe this therapy could also treat other cancers in the future.